Interaction between morphine and norketamine enantiomers in rodent models of nociception

Pharmacology Biochemistry and Behavior

Volumn 90, Issue 4, 2008, Pages 769-777

  Holtman Jr , Joseph R ^a,b   Crooks, Peter A ^b   Johnson Hardy, Jaime ^a   Wala, Elzbieta P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

Author keywords

NMDA receptor antagonist opioid receptor agonist combination therapy; R( ) norketamine; Rodent models of pain; S(+) norketamine

Indexed keywords

DRUG VEHICLE; FORMALDEHYDE; KETAMINE; MORPHINE SULFATE; NORKETAMINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; DRUG TOLERANCE; ENANTIOMER; HYPERALGESIA; LOCOMOTION; LOW DRUG DOSE; MALE; NERVE INJURY; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; ROTAROD TEST; TAIL FLICK TEST; TREATMENT INDICATION;

ANALGESICS, OPIOID; ANIMALS; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG TOLERANCE; EXCITATORY AMINO ACID ANTAGONISTS; FORMALDEHYDE; KETAMINE; MALE; MORPHINE; MOTOR ACTIVITY; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PHYSICAL STIMULATION; POSTURAL BALANCE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; STEREOISOMERISM;

RATTUS; RODENTIA;

EID: 48749094440     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2008.05.019     Document Type: Article

References (57)

1. Ballantine J.C. Opioids for chronic nonterminal pain. South Med J 99 (2006) 1245-1255
2. Ballantine G.J., and Mao J. Opioid therapy for chronic pain. N Eng J Med 13 (2003) 1943-1953
3. Belozertseva I.V., Dravolina O.A., Neznanova O.N., Danysz W., and Bespalov A.Y. Antinociceptive activity of combination of morphine and NMDA receptor antagonists depends on the inter-injection interval. Eur J Pharmacol 396 (2000) 77-83
4. Bell R., Eccleston C., and Kalso E. Ketamine as an adjuvant to opioids for cancer pain. A qualitative systemic review. J Pain Symptom Manage 26 (2003) 867-875
5. Bennett G. Update on the neurophysiology of pain transmission and modulation: focus on the NMDA receptor. J Pain Symptom Manage 19 (2000) 2-9
6. Bennett G., and Xie Y. A peripheral mononeuropathy in rat that produced disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
7. Benthuysen J.L., Hance A.J., Quam D.D., and Winters W.D. Comparison of isomers of ketamine on catalepsy in the rat and electrical activity of the brain and behavior in the cat. Neuropharmacology 28 (1989) 1003-1009
8. Campos A.R., Santos F.A., and Rao V.S. Ketamine-induced potentiation of morphine analgesia in rat tail-flick test: role of opioid-, alpha2-adrenoceptors and ATP-sensitive potassium channels. Biol Pharm Bull 29 (2006) 86-89
9. Celerier E., Rivat C., Jun Y., Laulin J.P., Larcher A., Reynier P., et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92 (2000) 465-472
10. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53 (1994) 55-63
11. Chaplan S.R., Malberg A.B., and Yaksh T.L. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharm Exp Ther 280 (1997) 829-838
12. Craft R.M., and Lee D.A. NMDA antagonist modulation of morphine antinociception in female and male rats. Pharm Biochem Behav 80 (2005) 639-640
13. D'Amour F.E., and Smith D.L. A method of determining loss of pain sensation. J Pharmacol Exp Ther 27 (1941) 74-79
14. Dickenson A. Mechanism of central hypersensitivity; excitatory amino acids mechanisms and their control. In: Dickenson A.H., and Besson J.M. (Eds). The pharmacology of pain (1997), Springer Verlag, Berlin 167-210
15. Ebert B., Mikkalsen S., Thorkildsen C., and Borgbjerg F. Norketamine, the main metabolite of ketamine, is non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur J Pharmacol 333 (1997) 99-104
16. Elia N., and Tramer M.R. Ketamine and postoperative pain - a qualitative systemic review of randomized trials. Pain 113 (2005) 61-70
17. Gilron I., and Max M.B. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurotherap 5 (2005) 823-830
18. Grass S., Hoffman O., Xu X.J., and Wiesenfeld-Halin Z. N-methyl-D-aspartate receptor antagonists potentiate morphine antinociceptive effect in the rat. Acta Physiol Scand 158 (1996) 269-273
19. Harden R.N. Chronic opioid therapy: another reappraisal. ASP Bull 12 (2002) 8-12
20. Hocking G., and Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 97 (2003) 1730-1739
21. Holtman Jr. J.R., and Wala E.P. Characterization of morphine-induced hyperalgesia in male and female rats. Pain 114 (2005) 62-70
22. Holtman Jr. J.R., Jing X., and Wala E.P. Sex-related differences in the enhancement of morphine antinociception by NMDA antagonists in rats. Pharm Biochem Behav 76 (2003) 285-293
23. Holtman Jr. J.R., Sloan J.W., and Wala E.P. Morphine tolerance in male and female rats. Pharm Biochem Behav 77 (2004) 517-523
24. Holtman Jr. J.R., Crooks P.A., Johnson J., and Wala E.P. NMDA receptor antagonists for chronic pain, can we do better than ketamine? (2007), PGA NYSSA 9015
25. Kalso E. Improving opioid effectiveness: from ideas to evidence. Eur J Pain 9 (2005) 131-135
26. Kauppila T., Xu X.J., Yu W., and Wiesenfeld-Hallin Z. Dextromethorphan potentiates the effect of morphine in rats with peripheral neuropathy. NeuroReport 9 (1998) 1071-1074
27. Kozela E., Danysz W., and Popik P. Uncompetitive NMDA receptor antagonist potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. Eur J Pharmacol 423 (2001) 17-26
28. Joo G., Horvath G., Klimscha W., Kekesi G., Dobos I., Szikszay M., et al. The effects of ketamine and its enantiomers on the morphine- or dexmedetomidine-induced antinociception after intrathecal administration in rats. Anesthesiology 93 (2000) 231-241
29. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., and Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 94 (2002) 1263-1269
30. Lauretti G.R., Gomes J.M., Reis M.P., and Pereira N.L. Low doses of epidural ketamine or neostygmine but not midazolam improve morphine analgesia in epidural terminal cancer pain therapy. J Clin Anesth 11 (1999) 663-668
31. Lemming D., Sorensen J., Graven-Nielsen T., Lauber R., Arendt-Nielsen L., and Gerdle B. Managing chronic whiplash associated with a combination of low dose opioid (remifentanil) and NMDA-antagonist (ketamine). Eur J Pain 11 (2007) 719-732
32. Leung A., Wallace M.S., Rigeway B., and Yaksh T. Concentration-effect relationship of intravenous alfentail and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 91 (2001) 177-187
33. Lomas L.M., Terner J.M., and Picker M.J. Sex differences in NMDA antagonist enhancement of morphine antihyperalgesia in a capsaicin model of persistent pain: comparisons to two models of acute pain. Pharmacol Biochem Behav 89 (2008) 127-136
34. Lossignol D.A., Obiols-Portis M., and Body J.J. Successful use of ketamine for intractable cancer pain. Support Care Cancer 13 (2005) 188-193
35. Mao J. NMDA and opioid receptors: their interaction in antinociception, tolerance and neuroplasticity. Brain Research Rev 30 (1999) 289-304
36. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical therapy. Pain 100 (2002) 213-217
37. Manning B.H., Mao J., Frenk H., Price D.D., and Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 67 (1996) 79-88
38. McCartney C.J., Sinha A., and Katz J. A quantitative systemic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia. Anesth Analg 98 (2004) 1385-1400
39. Nadeson R., Tucker A., Bajunaki E., and Goodchild C.S. Potentiation by ketamine of fentanyl antinociception. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems. Br J Anesth 88 (2002) 685-691
40. Nemmani K.V., Grisel J.E., Stowe J.R., Smith-Carliss R., and Mogil J.S. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time. Pain 109 (2004) 274-283
41. Nishiyama T. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur J Pharmacol 305 (2000) 203-210
42. Pelissier T., Laurido C., Kramer V., Hernandez A., and Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur J Pharmacol 477 (2003) 23-28
43. Plesan A., Hedman U., Xu X.J., and Wissenfeld-Hallin Z. Comparison of ketamine and dextromethorphan in potentiating the antinociceptive effect of morphine in rat. Anesth Analg 86 (1998) 825-829
44. Prince D.D., Mayer D.J., and Mao J. NMDA-receptor antagonists and opioid receptor interactions as related to analgesia and tolerance. J Pain Symptom Manage 19 (2000) S7-11
45. Randall L., and Selitto J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111 (1957) 409-419
46. Schulte H., Sollevi A., and Segerdahl M. The synergistic effect of combined treatment with systemic ketamine and morphine on experimentally induced windup-like pain in humans. Anesth Analg 98 (2004) 1574-1580
47. Shimoyama N., Shimoyama M., Intrussi C.E., and Elliott K.J. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 85 (1996) 1357-1366
48. Subramaniam K., Subramaniam B., and Steinbrook R. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 99 (2004) 482-495
49. Sveticic G., Eichenberger U., and Curatolo M. Safety of morphine with ketamine for postoperative patient-controlled analgesia: an audit with 1026 patients. Acta Anesthosiol Scand 49 (2005) 870-875
50. Van Elstraete A.C., Sitbon P., Trabold F., Mazoit J.X., and Benhamou D. A single dose of intrathecal morphine in rats induces long-lasting hyperalgesia: the protective effect of prior administration of ketamine. Anesth Analg 101 (2005) 1750-1756
51. Visser E., and Schug S.A. The role of ketamine in pain management. Biomed Pharmacotherapy 60 (2006) 341-348
52. Watzman N., Barry H., Buckley J.P., and Kinnard W.J. Semiautomatic system for timing rotarod performance. J Pharm Sci 53 (1964) 14-29
53. Wheeler-Aceto H., and Cowan A. Standardization of the rat paw formalin test for evaluation of analgesics. Psychopharmacol 104 (1991) 35-44
54. White J.M., and Ryan C.F. Pharmacological properties of ketamine. Drug Alcohol Rev 15 (1996) 145-155
55. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. Drugs 56 (1998) 1-4
56. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17 (1976) 1031-1036
57. Yamamoto T., and Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett 135 (1992) 67-70